Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Strong Anion Exchange Chromatography – V 2.0

Posted on By


Biosimilars: SOP for Strong Anion Exchange Chromatography – V 2.0


Standard Operating Procedure for Strong Anion Exchange Chromatography in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/161/2025
Supersedes SOP/BS/161/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a standard procedure for conducting strong anion exchange (AEX) chromatography for intermediate purification or polishing of biosimilar proteins by removing process-related impurities, host cell DNA, and viral particles.

2. Scope

This SOP is applicable to the use of strong AEX chromatography resins such as Q Sepharose, DEAE resins, or equivalent for downstream processing of biosimilar monoclonal antibodies or other recombinant proteins.

3. Responsibilities

  • Production: Perform column setup, equilibration, sample loading, elution, and cleaning.
  • QA: Review batch records, buffer logs, and chromatography process parameters.
  • Engineering: Ensure skid and sensor calibration and maintenance readiness.

4. Accountability

The Downstream Manufacturing Head is accountable for process adherence and completeness of documentation associated with AEX operations.

5. Procedure

5.1 Preparation

  1. Verify the resin type and column ID. Record resin lot and column pre-use status in Annexure-1.
  2. Prepare and filter buffers as per validated process:
    • Equilibration Buffer: 20 mM Tris-HCl, pH 8.0
    • Elution Buffer: same as equilibration buffer with 0–500 mM NaCl
    • Cleaning Buffer: 0.5 M NaOH
    • Storage Buffer: 20% ethanol in WFI
  3. Document buffer preparation parameters in Annexure-2.

5.2 Column Equilibration

  1. Mount column vertically and connect tubing correctly (ensure flow is top-to-bottom or per resin manufacturer).
  2. Equilibrate with 5–10 column volumes (CV) of equilibration buffer.
  3. Monitor and record UV (280 nm), conductivity, and pressure.

5.3 Sample Loading

  1. Ensure that the sample is filtered through 0.22 µm and is pH-adjusted to match equilibration buffer.
  2. Load sample at 100–200 cm/hr, maintaining pressure < 2 bar.
  3. Observe UV for breakthrough and confirm loading endpoint.

5.4 Washing and Elution

  1. Wash with 5 CV of equilibration buffer to remove unbound materials.
  2. Elute with NaCl gradient (e.g., 0–500 mM over 10 CV) or step elution.
  3. Collect fractions and analyze UV absorbance and conductivity to pool peak product fractions.

5.5 Column Cleaning and Storage

  1. Clean column using 0.5 M NaOH for 20–30 minutes at room temperature.
  2. Flush with WFI until neutral pH is reached.
  3. Store in 20% ethanol at 2–8°C if not used immediately.

5.6 Documentation

  1. Attach printouts of UV and conductivity profiles to batch records.
  2. Record all chromatography parameters in Annexure-3.
  3. Complete cleaning and storage log in Annexure-4.

6. Abbreviations

  • AEX: Anion Exchange Chromatography
  • CV: Column Volume
  • WFI: Water for Injection
  • NaCl: Sodium Chloride

7. Documents

  1. Column ID and Resin Log – Annexure-1
  2. Buffer Preparation Record – Annexure-2
  3. Chromatography Run Log – Annexure-3
  4. Cleaning and Storage Record – Annexure-4

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 999 – GMP for Biotherapeutics
  • OEM Guidelines – Cytiva, Repligen, Sartorius resin manuals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Column ID and Resin Log

Date Column ID Resin Type Lot No. Status Verified By
04/05/2025 AEX-Q-01 Q Sepharose QSP-01234 Ready Ajay Verma

Annexure-2: Buffer Preparation Record

Buffer pH Conductivity Prepared By Date Filter ID
Elution Buffer 8.0 45 mS/cm Sunita Reddy 04/05/2025 FL-2450

Annexure-3: Chromatography Run Log

Step Flow Rate UV Pressure Start Time End Time Operator
Sample Load 150 cm/hr 0.72 AU 1.4 bar 11:30 12:10 Ajay Verma

Annexure-4: Cleaning and Storage Record

Date Column ID Cleaning Agent Contact Time Final pH Storage Conditions
04/05/2025 AEX-Q-01 0.5 M NaOH 30 min 7.1 20% Ethanol @ 2–8°C

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Updated resin types and added hold time for cleaning Regulatory update
See also  Biosimilars: SOP for Regulatory Compliance for GMOs - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Elixir Department: SOP for Automated Transfer System Controls – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Calibration of Pressure Gauges in Manufacturing Areas – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version